TCEB1-mutated renal cell carcinoma: A distinct genomic and morphological subtype

Modern Pathology

Volumn 28, Issue 6, 2015, Pages 845-853

  Hakimi, A Ari ^a,b   Tickoo, Satish K ^b   Jacobsen, Anders ^b   Sarungbam, Judy ^b   Sfakianos, John P ^a   Sato, Yusuke ^c,d   Morikawa, Teppei ^c   Kume, Haruki ^c   Fukayama, Masashi ^c   Homma, Yukio ^c   Chen, Ying Bei ^b   Sankin, Alexander I ^a   Mano, Roy ^a   Coleman, Jonathan A ^a   Russo, Paul ^a   Ogawa, Seishi ^d   Sander, Chris ^b   Hsieh, James J ^b   Reuter, Victor E ^b  

^a Urology Service   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE IX; CYTOKERATIN 7; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; ELONGIN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME 8; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CYTOLOGY; CYTOPLASM; FEMALE; FOLLOW UP; GENE DOSAGE; GENE EXPRESSION; GENE LOCATION; GENE LOSS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; MIDDLE AGED; PATHOLOGIST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; TCEB1 GENE; TUMOR GENE; DNA MUTATIONAL ANALYSIS; GENETICS; GENOMICS; KIDNEY TUMOR; MUTATION; PATHOLOGY;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, RENAL CELL; DNA MUTATIONAL ANALYSIS; FEMALE; GENOMICS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MUTATION; TRANSCRIPTION FACTORS;

EID: 84930148173     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2015.6     Document Type: Article

References (17)

1. Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol 2013;37:1469-1489
2. Rohan SM, Xiao Y, Liang Y, et al. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel- Lindau gene and hypoxia-inducible factor pathwayrelated proteins. Mod Pathol 2011;24:1207-1220
3. Cancer Genome Atlas Research N, Analysis working group: Baylor College of MCreighton CJ, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013;499:43-49
4. Sato Y, Yoshizato T, Shiraishi Y, et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet 2013;45:860-867
5. Varela I, Tarpey P, Raine K, et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011;469:539-542
6. Hakimi AA, Chen YB, Wren J, et al. Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma. Eur Urol 2013;63:848-854
7. Kapur P, Pena-Llopis S, Christie A, et al. Effects on survival of BAP1 and PBRM1 mutations in sporadic clearcell renal-cell carcinoma: a retrospective analysis with independent validation. Lancet Oncol 2013;14:159-167
8. Hakimi AA, Ostrovnaya I, Reva B, et al. Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network. Clin Cancer Res 2013;19: 3259-3267
9. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005;102:15545-15550
10. Martignoni G, Brunelli M, Segala D, et al. Renal cell carcinoma with smooth muscle stroma lacks chromosome 3p and VHL alterations. Mod Pathol 2014;27: 765-774
11. Medendorp K, van Groningen JJ, Schepens M, et al. Molecular mechanisms underlying the MiT translocation subgroup of renal cell carcinomas. Cytogenet Genome Res 2007;118:157-165
12. Ramphal R, Pappo A, Zielenska M, et al. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. Am J Clin Pathol 2006;126:349-364
13. Beroukhim R, Brunet JP, Di Napoli A, et al. Patterns of gene expression and copy-number alterations in vonhippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res 2009;69: 4674-4681
14. Nickerson ML, Jaeger E, Shi Y, et al. Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res 2008;14: 4726-4734
15. Kibel A, Iliopoulos O, DeCaprio JA, et al. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science 1995;269:1444-1446
16. Aso T, Lane WS, Conaway JW, et al. Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II. Science 1995;269:1439-1443
17. Michal M, Hes O, Kuroda N, et al. Difference between RAT and clear cell papillary renal cell carcinoma/clear renal cell carcinoma. Virchows Arch 2009;454:719